logo_image
Headline: Plus Therapeutics Announces Key RNL™ Development and cGMP Drug Manufacturing Collaboration Agreements
Location: San Antonio, TX, US
Post Date: May 4, 2021 7:30 AM
TAG ID: pznews229990
DocID: 202105048228542-en.xml
Word Count: approx. 1228 words
 
Plus Therapeutics Announces Key RNL⢠Development and cGMP Drug Manufacturing Collaboration Agreements â Agreements are a major step for ongoing clinical trials and future commercial drug supply
 
Please login to download this Story